G M HASS
Overview
Explore the profile of G M HASS including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
PINKERTON H, HASS G
J Exp Med
. 2009 Oct;
56(1):145-50.
PMID: 19870051
The temperature at which tissue cultures infected with typhus Rickettsiae are incubated has been shown to exert a marked influence on the intracellular multiplication of Rickettsia prowazeki. At 41 degrees...
12.
PINKERTON H, HASS G
J Exp Med
. 2009 Oct;
56(1):131-43.
PMID: 19870050
In tissue cultures grown at 32 degrees C., typhus Rickettsiae increase rapidly within the cytoplasm of infected cells up to about the 14th day. At this time practically every cell...
13.
PINKERTON H, HASS G
J Exp Med
. 2009 Oct;
54(3):307-14.
PMID: 19869918
Typhus Rickettsiae are found in large numbers in sections of tissue cultures of scrotal sac exudate. Extensive multiplication of the organisms occurs, and new cells become infected. Organisms are seen...
14.
HASS G, Meyer J, Newitt R, Labuda T, Brown L, Aebersold R, et al.
Hybridoma
. 2001 Oct;
20(4):231-6.
PMID: 11604108
The monoclonal antibody (MAb) A6H, originally developed to fetal renal tissues, was found to be highly reactive to renal cell carcinoma and was subsequently demonstrated to co-stimulate a subpopulation of...
15.
Wang S, Diamond D, HASS G, Sokoloff R, Vessella R
Int J Cancer
. 2001 May;
92(6):871-6.
PMID: 11351309
Recently we described the generation of the prostate tissue-specific monoclonal antibody (MAb) 107-1A4, its expression pattern and preliminary targeting of human prostate cancer xenografts. In this report we demonstrate that...
16.
Corey M, Kinders R, Poduje C, Bruce C, Rowley H, Brown L, et al.
J Biol Chem
. 2000 Apr;
275(17):12917-25.
PMID: 10777591
We have recently reported that complement factor H, a negative regulator of complement-mediated cytotoxicity, is produced and secreted by most bladder cancers. This observation was exploited in the development of...
17.
Kinders R, Jones T, Root R, Bruce C, Murchison H, Corey M, et al.
Clin Cancer Res
. 1998 Oct;
4(10):2511-20.
PMID: 9796985
The BTAstat and BTA TRAK tests are new immunoassays that detect and measure an antigen in the urine of individuals diagnosed with bladder cancer. As described in this report, the...
18.
Carlin B, Marachie J, Venegas M, Schaeffer A, Shaw N, HASS G, et al.
Prostate
. 1994 Sep;
25(3):156-61.
PMID: 7520579
In this preliminary study, we report that an enzyme-linked immunofluorescence assay (EFLA) was developed for the determination of PR92 antigen in prostatic fluid, utilizing anti-PR92 monoclonal antibody. Fluid samples from...
19.
Xu F, Yu Y, Daly L, Anselmino L, HASS G, Berchuck A, et al.
Cancer
. 1994 Apr;
73(7):1855-8.
PMID: 8137210
Background: Endometrial carcinoma is generally diagnosed only after the onset of postmenopausal bleeding. Although most patients with Stage I disease can be cured, the prognosis worsens significantly when the tumor...
20.
Xu F, Yu Y, Daly L, DeSombre K, Anselmino L, HASS G, et al.
J Clin Oncol
. 1993 Aug;
11(8):1506-10.
PMID: 8336189
Purpose: At second-look surgical surveillance procedures, normal CA-125 levels can be associated with persistent disease in 50% to 60% of patients. A novel radioimmunoassay (RIA) has been evaluated for the...